Inhibition of PCAF histone acetyltransferase and cytotoxic effect of N-acylanthranilic acids

Arch Pharm Res. 2012 Aug;35(8):1379-86. doi: 10.1007/s12272-012-0807-2. Epub 2012 Sep 1.

Abstract

Small molecule HAT inhibitors are useful tools to unravel the role of histone acetyltransferases (HATs) in the cell and have relevance for oncology. We synthesized a series of N-acylanthranilic acids (11-16) and of N-acyl-5-hydroxyanthranilic acids (17-22) bearing C6, C8, C10, C12, C14, along with C16 acyl chain at the 2-amino position of anthranilic acid or 5-hydroxyanthranilic acid. Enzyme inhibition of these compounds was investigated, using in vitro PCAF HAT assays. All synthesized compounds (65-76%) showed similar inhibitory activity to anacardic acid (68%) at 100 μM. The cytotoxicity, against one normal cell line (HSF) and eight cancer cell lines (HT-29, HCT-116, MDA-231, A-549, Hep3B, Caski, HeLa and Caki), were evaluated by the SRB method.

Publication types

  • Comparative Study

MeSH terms

  • Anacardic Acids / pharmacology
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Cell Line
  • Cell Line, Tumor
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / pathology
  • Structure-Activity Relationship
  • ortho-Aminobenzoates / chemical synthesis
  • ortho-Aminobenzoates / chemistry
  • ortho-Aminobenzoates / pharmacology*
  • p300-CBP Transcription Factors / antagonists & inhibitors*

Substances

  • Anacardic Acids
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • ortho-Aminobenzoates
  • anacardic acid
  • p300-CBP Transcription Factors
  • p300-CBP-associated factor